PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32162808-8	2020	Patients with tumor PD-L1 >= 1% had a significantly longer DFS in sequential chemotherapy than in than 5-FU/LV arm (interaction p = .04) and a trend for OS (interaction p = .12).	Leucovorin	108-110	CD274 molecule	Homo sapiens	20-25	
32162808-12	2020	Moreover, tumor PD-L1 expression >=1% was associated with greater benefit from intensive sequential chemotherapy compared with 5-fluorouracil plus leucovorin (5-FU/LV), whereas PD-L1 expression <1% was not, conditioning a statistically significant interaction between such biomarker and treatment arms.	Leucovorin	164-166	CD274 molecule	Homo sapiens	16-21	
31767795-8	2019	Patients with tumor PD-L1 >= 1% had a significantly longer DFS in sequential chemotherapy than in than 5-FU/LV arm (interaction p = .04) and a trend for OS (interaction p = .12).	Leucovorin	108-110	CD274 molecule	Homo sapiens	20-25	
31767795-12	2019	Moreover, tumor PD-L1 expression >=1% was associated with greater benefit from intensive sequential chemotherapy compared with 5-fluorouracil plus leucovorin (5-FU/LV), whereas PD-L1 expression <1% was not, conditioning a statistically significant interaction between such biomarker and treatment arms.	Leucovorin	164-166	CD274 molecule	Homo sapiens	16-21